PharmaNet Development Group, Inc. has opened a new Phase I clinic in Toronto, Canada and new offices in Brussels, Belgium and Milan, Italy. The company has also relocated its Zurich, Switzerland office to allow for future growth of its staff.
"In support of the continued growth in demand for clinical development services and the trend towards more large, global studies, we are opening additional office locations and clinics to intensify our presence in the region and meet the needs of our clients around the world," commented Jeffrey P. McMullen, president and chief executive officer, PharmaNet Development Group, Inc. "We believe this continued expansion will allow us to serve our clients better."
The new facility in Toronto is approximately 40,000 sq. ft. and has four clinical units with 160 beds. The new offices in Brussels, Milan and Zurich will support late stage clinical development programs in these regions. Each office includes room for future expansion. The Brussels office, which opened last month, houses a staff of five. The Milan office, which opened earlier this month, currently accommodates nine employees and supports several field-based regional staff. The new location in Zurich currently accommodates 26 employees.
Magazine
